Growth policies for biopharmaceutical companies : a dynamic problem definition
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G. & Lasagna, Louis, 1991. "Cost of innovation in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 10(2), pages 107-142, July.
- Roberts, Edward B. & Hauptman, Oscar, 1986. "The process of technology transfer to the new biomedical and pharmaceutical firm," Research Policy, Elsevier, vol. 15(3), pages 107-119, June.
- Sterman, John., 1994. "Learning in and about complex systems," Working papers 3660-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
- John D. Sterman & Nelson P. Repenning & Fred Kofman, 1997. "Unanticipated Side Effects of Successful Quality Programs: Exploring a Paradox of Organizational Improvement," Management Science, INFORMS, vol. 43(4), pages 503-521, April.
- Schnee, Jerome E, 1972. "Development Cost: Determinants and Overruns," The Journal of Business, University of Chicago Press, vol. 45(3), pages 347-374, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Hazhir Rahmandad & Nelson Repenning, 2016. "Capability erosion dynamics," Strategic Management Journal, Wiley Blackwell, vol. 37(4), pages 649-672, April.
- Repenning, Nelson P. (Nelson Peter), 1998. "The transition problem in product development," Working papers WP 4036-98., Massachusetts Institute of Technology (MIT), Sloan School of Management.
- Jalali, Mohammad S. & Rahmandad, Hazhir & Bullock, Sally Lawrence & Lee-Kwan, Seung Hee & Gittelsohn, Joel & Ammerman, Alice, 2019. "Dynamics of intervention adoption, implementation, and maintenance inside organizations: The case of an obesity prevention initiative," Social Science & Medicine, Elsevier, vol. 224(C), pages 67-76.
- Federico Cosenz & Guido Noto, 2016. "Applying System Dynamics Modelling to Strategic Management: A Literature Review," Systems Research and Behavioral Science, Wiley Blackwell, vol. 33(6), pages 703-741, November.
- Mohammad S. Jalali & Hazhir Rahmandad & Sally Lawrence Bullock & Alice Ammerman, 2017. "Dynamics of Implementation and Maintenance of Organizational Health Interventions," IJERPH, MDPI, vol. 14(8), pages 1-24, August.
- Edward G. Anderson & David R. Keith & Jose Lopez, 2023. "Opportunities for system dynamics research in operations management for public policy," Production and Operations Management, Production and Operations Management Society, vol. 32(6), pages 1895-1920, June.
- John Sterman, 2018. "System dynamics at sixty: the path forward," System Dynamics Review, System Dynamics Society, vol. 34(1-2), pages 5-47, January.
- Lu, Jinfeng & Dimov, Dimo, 2023. "A system dynamics modelling of entrepreneurship and growth within firms," Journal of Business Venturing, Elsevier, vol. 38(3).
- Laura Schmitt Olabisi & Amadou Sidibé, 2023. "Observations from a system dynamics modeling field school in Mali," System Dynamics Review, System Dynamics Society, vol. 39(1), pages 80-94, January.
- Day Yang Liu & Wen Chun Tsai & Pei Leen Liu & Chung Yi Fang, 2021. "Determinants of sales revenue in innovation diffusion effects of Taiwan sports lottery during the FIFA World Cup 2018," International Journal of Research in Business and Social Science (2147-4478), Center for the Strategic Studies in Business and Finance, vol. 10(4), pages 43-58, June.
- Oliva, Rogelio, 2003. "Model calibration as a testing strategy for system dynamics models," European Journal of Operational Research, Elsevier, vol. 151(3), pages 552-568, December.
- Katarzyna Tworek & Katarzyna Walecka-Jankowska & Anna Zgrzywa-Ziemak, 2019. "The role of information systems in shaping integrative logic for business sustainability," Operations Research and Decisions, Wroclaw University of Science and Technology, Faculty of Management, vol. 29(4), pages 125-146.
- Scherer, F.M., 2010. "Pharmaceutical Innovation," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 539-574, Elsevier.
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022.
"Generic competition and the incentives for early-stage pharmaceutical innovation,"
Research Policy, Elsevier, vol. 51(10).
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
- Grabowski, Henry & Vernon, John & DiMasi, Joseph, 2002.
"Returns on R&D for 1990s New Drug Introductions,"
Working Papers
02-21, Duke University, Department of Economics.
- Henry Grabowski & John Vernon & Joseph DiMasi, 2003. "Returns on R&D for 1990s New Drug Introductions," Levine's Working Paper Archive 618897000000000666, David K. Levine.
- Cardoso de Mendonca, Mario Jorge & Sachsida, Adolfo & Loureiro, Paulo R. A., 2003. "A study on the valuing of biodiversity: the case of three endangered species in Brazil," Ecological Economics, Elsevier, vol. 46(1), pages 9-18, August.
- Cäker, Mikael & Siverbo, Sven, 2018. "Effects of performance measurement system inconsistency on managers’ role clarity and well-being," Scandinavian Journal of Management, Elsevier, vol. 34(3), pages 256-266.
- Natalia Ciobanu & Ali Kerem Saysel, 2021. "Using social–ecological inventory and group model building for resilience assessment to climate change in a network governance setting: a case study from Ikel watershed in Moldova," Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development, Springer, vol. 23(1), pages 1065-1085, January.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
- Gopesh Anand & John Gray & Enno Siemsen, 2012. "Decay, Shock, and Renewal: Operational Routines and Process Entropy in the Pharmaceutical Industry," Organization Science, INFORMS, vol. 23(6), pages 1700-1716, December.
More about this item
Keywords
HD28 .M414 no.4020-98;JEL classification:
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:mit:sloanp:2713. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: None (email available below). General contact details of provider: https://edirc.repec.org/data/ssmitus.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.